Compared to WT controls, PirBTM cells from MLL-AF9 AML mice had significantly decreased phosphorylation of CAMKI, CAMKII, and CAMKIV (Sun et al. [22]) (Fig. 1a), suggesting that CAMK activities are regulated by the PirB signaling pathway. The gene discussed is KMT2A; the disease is acute myeloid leukemia.